It produces a variety of glycoconjugates, including human ganglioside analogs and multiple activators of TLRs, and targets MyD88, TRIF, macrophage galactose-type lectin (MGL), etc., which induces autoimmune diseases (131). This evidence concerns the gene CLEC10A and autoimmune disease.